The gene encoding for the catalytic sub-unit alpha of PI3K kinase, PIK3CA, is the most frequently mutated oncogene in ER-positive/HER2-negative/luminal cancers in all three cohorts and is significantly enriched in tumors with high mutation counts. Here, ERBB2 is linked to cancer.